On behalf of the organizing committee I invite you to attend the 7th Thomas Ashworth CTC & Liquid Biopsy Symposium 2021 to be held in-person at the Aerial UTS Function Centre, Sydney, Australia. This elevated 7th floor space is a well-designed conference venue located in the vibrant UTS Ultimo precinct close to Central Railway Station. We hope it will inspire both speakers and attendees to engage enthusiastically in the liquid biopsy discussion. In addition, we will be supporting virtual attendance.
The Symposium will run over 2 days enabling us to cover cutting-edge advances in liquid biopsy translational research and clinical practice. The program will begin at 12noon on Thursday 21 October, with registration from 11am, and close at 3.30pm on Friday 22 October.
The aim of the Symposium is to enrich our understanding of the clinical application of liquid biopsy to advance precision oncology and improve patient outcome, as well as provide critical insights into the metastatic process and application of liquid biopsy in different contexts.. An exciting line up of invited international speakers who are leaders in the field, along with invited national speakers from across Australia, will be showcasing their liquid biopsy research.
Topics that will be explored include circulating tumour cells, exosomes, methylated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring as well as drug resistance monitoring. The health economics of liquid biopsy will be presented, along with discussion on the regulatory landscape.
This year we will again highlight the "Making an IMPACT" keynote presentation that will showcase research by an Australian researcher that has significant discovery impact or will likely achieve a clinical impact and be likely translated into routine practice.
One final change that will occur this year is a call for oral presentations selected from submitted abstracts. All abstracts will be reviewed be a panel and those chosen for oral presentation will be notified a few weeks prior to the Symposium. Poster presentations are also welcomed from delegates. Generous awards will be given for the best young investigator oral presentations and poster presentation. - so please submit an abstract. This is a great opportunity.
Who should attend?
The organising committee maintains a philosophy of keeping registration costs as low as possible to encourage attendance and this is only possible due to the generous support of our sponsors. So please ensure to visit the exhibitor tables and check out their latest product offerings.
We look forward to seeing you at the Symposium in October.
Associate Professor Kevin Spring
Convenor, 7th Thomas Ashworth CTC & Liquid Biopsy Symposium
Professor Razelle Kurzrock, MD, PhD.
University of California, San Diego, USA
Professor Sarah-Jane Dawson, MBBS, PhD.
Peter McCallum Cancer Centre, Melbourne Australia
Dr Ira Deveson, PhD
Kinghorn Centre for Clinical Genomics, Sydney, Australia